With more than 25 million people now living with diabetes in the U.S., the condition has grown into an epidemic.

Fortunately, researchers at the University of Minnesota are leading efforts to combat this trend with some of the most innovative research and treatments currently in process anywhere in the world.

Clinically, researchers in the Schulze Diabetes Institute and other university groups are closing in on potential cures and better treatments. The U of M is one of a handful of institutions worldwide to offer islet transplantation.

We’ve also participated in groundbreaking studies of diabetes' link to heart disease. Our researchers continue to refine treatments, in an attempt to reverse or better control this devastating disease.

The Center for Immunology has already made an impact in the field, despite being around for only a few years. The center has developed new methods for diagnosing Type I diabetes earlier in the disease process, which enable earlier initiation of treatment.

Research spotlight

Researchers in the University of Minnesota’s Schulze Diabetes Institute are driven to reverse Type 1 Diabetes through pioneering islet transplantation treatments.

Meet an expert

Bernhard J. Hering, M.D.

Pancreatic islet cell transplantation can prevent episodes of severe hypoglycemia in people who have type 1 diabetes and restore blood sugar awareness and control. That’s the conclusion of a national Phase III clinical trial published April 18, 2016, in the online edition of the peer-reviewed journal Diabetes Care.

The University of Minnesota’s Bernhard J. Hering, M.D., executive director of the Schulze Diabetes Institute and a professor of surgery and medicine, was the lead author of the paper.